FDA approves cellular therapy for patients with Type 1 diabetes
The U.S. Food and Drug Administration (FDA) has now approved Lantidra, the first allogeneic (donor) pancreatic islet cellular therapy made from deceased donor pancreatic cells for
The U.S. Food and Drug Administration (FDA) has now approved Lantidra, the first allogeneic (donor) pancreatic islet cellular therapy made from deceased donor pancreatic cells for